Shkreli resigns as Turing Pharma CEO

December 18, 2015 5:58 PM

34 0

Martin Shkreli, the medical entrepreneur reviled for ordering large drug price hikes, resigned Friday as CEO of Turing Pharmaceuticals, one day after federal authorities charged him in an unrelated securities fraud scheme.

The privately held company announced that Ron Tilles, the chairman of the privately-held biopharmaceutical company, will serve as interim CEO while retaining his current position.

Also read: New charge brought against Oklahoma bomb plot defendant

Read more

To category page